[1] |
Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America[J]. Clin Infect Dis, 2008, 46(3): 327⁃360. DOI: 10.1086/525258.
|
[2] |
Ma JE, Yun EY, Kim YE, et al. Endobronchial aspergilloma: report of 10 cases and literature review[J]. Yonsei Med J, 2011, 52(5): 787⁃792. DOI: 10.3349/ymj.2011.52.5.787.
|
[3] |
Limper AH, Knox KS, Sarosi GA, et al. An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients[J]. Am J Respir Crit Care Med, 2011, 183(1): 96⁃128. DOI: 10.1164/rccm.2008⁃740ST.
|
[4] |
Brakhage AA, Liebmann B. Aspergillus fumigatus conidial pigment and cAMP signal transduction: significance for virulence[J]. Med Mycol, 2005, 43 Suppl 1: S75⁃82.
|
[5] |
Pihet M, Vandeputte P, Tronchin G, et al. Melanin is an essential component for the integrity of the cell wall of Aspergillus fumigatus conidia[J]. BMC Microbiol, 2009, 9: 177. DOI: 10.1186/1471⁃2180⁃9⁃177.
|
[6] |
Jahn B, Koch A, Schmidt A, et al. Isolation and characterization of a pigmentless⁃conidium mutant of Aspergillus fumigatus with altered conidial surface and reduced virulence[J]. Infect Immun, 1997, 65(12): 5110⁃5117.
|
[7] |
Tsai HF, Washburn RG, Chang YC, et al. Aspergillus fumigatus arp1 modulates conidial pigmentation and complement deposition[J]. Mol Microbiol, 1997, 26(1): 175⁃183.
|
[8] |
Langfelder K, Jahn B, Gehringer H, et al. Identification of a polyketide synthase gene (pksP) of Aspergillus fumigatus involved in conidial pigment biosynthesis and virulence[J]. Med Microbiol Immunol, 1998, 187(2): 79⁃89.
|
[9] |
Zhang C, Kong Q, Cai Z, et al. The newly nonsporulated characterization of an Aspergillus fumigatus isolate from an immunocompetent patient and its clinic indication[J]. Fungal Genet Biol, 2015, 81: 250⁃260. DOI: 10.1016/j.fgb.2015.03.001.
|
[10] |
Jahn B, Koch A, Schmidt A, et al. Isolation and characterization of a pigmentless⁃conidium mutant of Aspergillus fumigatus with altered conidial surface and reduced virulence[J]. Infect Immun, 1997, 65(12): 5110⁃5117.
|
[11] |
Park SY, Lee SO, Choi SH, et al. Serum and bronchoalveolar lavage fluid galactomannan assays in patients with pulmonary aspergilloma[J]. Clin Infect Dis, 2011, 52(7): e149⁃152. DOI: 10.1093/cid/cir027.
|
[12] |
高露娟, 余进, 李若瑜. 中国大陆地区曲霉病流行现状分析[J]. 中国真菌学杂志, 2010, 5(4): 247⁃251. DOI: 10.3969/j.issn.1673⁃3827.2010.04.016.
|
|
Gao LJ, Yu J, Li RY. Epidemiology of aspergillosis in mainland China[J]. Chin J Mycol, 2010, 6(4): 247⁃251. DOI: 10.3969/j.issn.1673⁃3827.2010.04.016.
|
[13] |
Katz ME, Dougall AM, Weeks K, et al. Multiple genetically distinct groups revealed among clinical isolates identified as atypical Aspergillus fumigatus[J]. J Clin Microbiol, 2005, 43(2): 551⁃555. DOI: 10.1128/JCM.43.2.551⁃555.2005.
|
[14] |
高露娟, 余进, 李若瑜. 烟曲霉再鉴定、标准化CSP分型及体外药物敏感性[J]. 中国真菌学杂志, 2011, 6(6): 328⁃331, 316. DOI: 10.3969/j.issn.1673⁃3827.2011.06.003.
|
|
Gao LJ, Yu J, Li RY. Re⁃identification, standard CSP typing and in vitro susceptibility of Aspergillus complex[J]. Chin J Mycol, 2011, 6(6): 328⁃336. DOI: 10.3969/j.issn.1673⁃3827.2011. 06. 003.
|